Opthea Announced The Publication Of Its Phase 1b Trial Of Sozinibercept Combination Therapy In Diabetic Macular Edema In The Peer-reviewed Journal Translational Vision Science & Technology

Benzinga · 01/07 12:09
  • Phase 1b clinical data underpins sozinibercept's potential as a novel, first-in-class VEGF-C/D ‘trap' to improve visual and anatomic outcomes in DME
  • Published in peer-reviewed journal Translational Vision Science & Technology and included in the Anti-VEGF Special Journal Issue of ARVO
  • DME program to be advanced after wet AMD topline data readout anticipated for COAST in early CY Q2 2025 and ShORe in mid-2025